Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not surprised to hear about the demand for labs. The mmar folks make fun of Tweed for investing in a top class lab,.. meanwhile the tinfoil hat crew will just smoke anything as the rest of the world changes to high quality standards.
The potential for Nevada to become a tourism hub for marijuana has created significant demand for laboratory testing services. In the case of recreational marijuana, there is a high likelihood that testing will be a built-in requirement, while medical marijuana patients have become increasingly concerned that the medicine they're purchasing may not have the ingredients they need.
Organovo Signs Multi-Year 3D Bioprinting Deal with Pharma Giant Merck
http://3dprintingindustry.com/2015/04/23/organovo-signs-multi-year-3d-bioprinting-deal-with-pharma-giant-merck/
Organovo Signs Multi-Year 3D Bioprinting Deal with Pharma Giant Merck
Michael Molitch-Hou BY MICHAEL MOLITCH-HOU ON THU, APRIL 23, 2015 · 3D PRINTING, BIOPRINTING, BUSINESS, MEDICAL & DENTAL, NEWS, RESEARCH
After signing a groundbreaking deal with cosmetics company L’Oreal for the development of 3D printed skin for cosmetics testing, Organovo continues to make partners in powerful places. On April 17, the bioprinting company filed a Form 8-K with the SEC stating a multi-year partnership with pharmaceutical giant Merck & Co. that involves both the use of the company’s exVive3D liver tissues and the use of their NovoGen Bioprinting system for developing medicines. The exact wording of the document is as follows:
On April 17, 2015, Organovo (NYSE: ONVO) entered into a multi-year research collaboration agreement with Merck Sharp & Dohme Corp. (NYSE: MRK). The Agreement will give Merck access to Organovo’s commercial exVive3DTM Human Liver Tissue service, and will also involve a collaboration to develop multiple custom tissue models utilizing the Company’s proprietary NovoGen Bioprinting PlatformTM, for use in drug development.
This deal, along with the pre-announcement of preliminary Q4 and 2014 earnings, drove the company’s stock up about 17% this morning, before it dropped back down almost 2% below its last closing stock price. But, forget stock prices! The company is on a roll lately. In addition to partnerships, Organovo just announced the development of 3D printed kidney cells, which can be further used to test the affects of medicines.
organovo 3d bioprinter
Merck, according to Wikipedia, has had more drugs approved than any other company, some of which are used for the treatment of diabetes, high cholesterol, autoimmune diseases, HIV, and HPV. Though Merck has also been responsible for failing to pay Medicaid rebates and occasional pollution, the company seems to have addressed those controversies, once they were revealed to the public and federal agencies. My fingers are crossed that this member of Big Pharma is one of the “good ones”, but, then again, the world is a scary place. And, because Merck is famous for developing the first mumps, rubella, Hepatitis B, and varicella vaccines, I’m hoping that they’ll also be the first pharmaceutical business to develop medicines using 3D printed liver cells. And, if things go really well with Organovo, maybe they’ll even be the first to 3D print entire livers.
If you don't know Lift, then you have been living under a rock.
More Insider Buying.
https://www.canadianinsider.com/node/7?menu_tickersearch=MZI+%7C+Mezzi+Holdings
As of 11:59pm ET April 28th, 2015
Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price
Apr 28/15 Apr 28/15 Driver, Cyrus Direct Ownership Common Shares 11 - Acquisition carried out privately 480,000
Apr 13/15 Apr 10/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.180
Apr 13/15 Apr 9/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.200
Mar 31/15 Mar 27/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 20,000 $0.200
Mar 30/15 Mar 27/15 Keir, Reynolds Direct Ownership Common Shares 11 - Acquisition carried out privately 2,224,500 $0.140
Mar 25/15 Mar 23/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.230
Mar 23/15 Mar 20/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 75,000 $0.190
Mar 23/15 Mar 20/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 15,000 $0.175
Mar 19/15 Mar 19/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.160
Mar 19/15 Mar 19/15 Keir, Reynolds Indirect Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.155
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Out of the 10 selections currently available 6 have not been cold-pasteurized and 4 of them have. You do realize patients coping with reduced immune systems require cold-pasteurized mmj right?
To me, reading Vancouver News is the same as reading the news in Dominica. On occasion I will read Dominica news online. http://dominicanewsonline.com/news/ I find it mesmerizing how differently peoples "brains" will think, depending on the environment they live in. The world is surely one nutty place.
"Any kind of regulation helps," said Vancouver Police Department superintendant Mike Porteous.
How about those Health Canada regulations Mike?
Unfortunately it doesn't detail exactly who the analysts are.
TWEED MARIJUANA INC : Price Target $3
http://www.4-traders.com/TWEED-MARIJUANA-INC-21040136/consensus/
Consensus
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 3,00 CAD
Last Close Price 2,05 CAD
Spread / Highest target 59%
Spread / Average Target 46%
Spread / Lowest Target 34%
Organovo Holdings’s “Buy” Rating Reiterated at Cantor Fitzgerald (ONVO)
Nice that Cantor has a Buy rating on this,. however it is not cool to reiterate a target price that is so low. Not sure why they are trying to build this $5 roof into the stock,.. annoying.
http://sleekmoney.com/organovo-holdingss-buy-rating-reiterated-at-cantor-fitzgerald-onvo/223243/
Now isn't that honestly the real "Fact of the matter".
Sign up for the legal route that HC has approved.
Too funny, Bonno is just as clueless,.. "Proud Canadians growers!"
Yup, TWEED is Proud to be one of the Largest Canadian Growers!!!
Tweed is KING!
One too many bong hits for Bob, pumping MMPR's, gotta love the tin foil hat nation!!
Those "twigs" surely have a nice tasty BUD wrapped around them,. Carter is licking his chops right now. :)
Nice to see BOB pumping the MMPR's too!! Cool
Who are the CGC members?
Our members are any of the 36,000+ PPL or DPPL license holders under the MMAR regulations, applicants and licensed producers under the MMPR regulations, as well as any individual or business who supports our causes.
Short position has dropped off to near nothing.
Short Positions for TWD
Symbol Report Date Volume Change Shares Issued % Float
V : TWD 2015-04-15 54,710 -29,100 50,752,666 0.11
V : TWD 2015-03-31 83,810 -1,467,700 49,957,306 0.17
V : TWD 2015-03-15 1,551,510 630,200 40,640,700 3.82
V : TWD 2015-02-28 921,310 514,600 40,640,700
No Health Official backed this. Perry Kendall is "retired", his opinion means nothing.
Extremely dangerous for the shorts, they are loco. Looks like more short positions were opened this morning too.
Where would the SP be if all the short positions were closed... food for thought.
Thanks for posting, now that was a well written and to the point article. Looks like one person in Vancouver isn't high and understands the big picture. Good job Ian Mulgrew!
My favorite quote in the article...
More than that, I’d like to hear him explain how you can buy marijuana wholesale without dealing with criminals or gangsters?
I am very surprised Vancouver is suggesting this system for their city. They are aware of the cases in the court system along with the mmpr regulations and the direction HC wants to go. One would think they would wait for the outcome of the court cases before being tied to a new system, which would be something else that would end up going to court depending on the outcome of the existing court cases. The whole thing sounds somewhat fishy to me that they are suggesting this now.
It has been 10 years since I was in Vancouver but even back then people were smoking joints very openly in public, one fellow smoking a fatty while basking in the sun on the stair steps of a Bank. Being from Toronto it was surprising for me to witness how openly people smoked. So I presume with another decade of that sort of environment the general population has become somewhat immune to the concept that it is "illegal". It is somewhat of a cultural phenomenon of the environment they live within, while you can go to the east coast of Canada where you would be arrested for smoking in public. This would make quite the case study for a sociology major, east coast versus west coast.
One would think that, but if we are following two sets of rules because of Vancouver, why not? One set of rules for the "country" of Vancouver and one set of rules for the real country of Canada. This is what I am saying, big can of worms is being opened in Vancouver. How can the Federal government deny Tweed of a store in Vancouver when full fledged criminals are allowed to open one??? That would be simply ridiculous, think about it.
Another way of looking at it. Who is to say Tweed can't open a sister company for example purposes, and that sister company opens the store in Vancouver. It isn't Tweed, it is a sister company store front.
What really needs to happen,.. Fed's need to step in and tell Vancouver to kibosh their ridiculous idea. Who is the city of Vancouver to decide what is legal and what is not?
I just wish my government would smarten up and work on the same page. My birth city of Vancouver appears to have decided they are their own country? What a can of worms Vancouver is opening up.
I guess we will see at least one Tweed dispensary popping up in Vancouver soon if it is only 30K and Vancouver wants to make their own rules for their little city/country...
It surely is going to get real confusing.
BY BRITTNEY SEVENSON · APRIL 23, 2015
http://3dprint.com/60245/organovo-merck-3d-print/
Organovo & Merck Enter Multi-year Research Partnership for 3D Printed Human Tissue
BY BRITTNEY SEVENSON · APRIL 23, 2015
inShare
36
o3The 3D bioprinting space may be about to take off in a big way. As investment dollars flow into companies seeking to transform medicine via the 3D printing of biological material, innovated new approaches are emerging, and researchers are certainly excited.
It’s been about five months since we reported on Organovo’s launch of the world’s first commercially available 3D printed human tissue, exVive3D. ExVive3D will eventually be a line of several 3D printed human tissues, however,the liver was the first that they launched.o2
While Organovo’s (NYSE:ONVO) stock price may be in the basement, it appears that the company itself is firing on all cylinders. Since the November launch of exVive3D, they’ve announced an exVive3D printable kidney tissue will also be coming to market next year, as well as initial plans for products within the cosmetic space. Additionally, CEO Keith Murphy estimated that within 4-6 years the company will be able to 3D print human organ patches to repair damaged organs.
That’s not all though. Organovo has been busy signing deals with larger corporations for research partnerships. Just two weeks ago, the company announced that they had reached a collaboration agreement with L’Oréal USA for research within the cosmetic space, gaining access to their skin cell technology.
o4
In a major announcement yesterday, Organovo reached yet another research agreement, this time with Merck Sharp & Dohme Corp., a subsidiary of Merck & Co (NYSE:MRK). The deal, which was signed on April 17th and filed with the SEC just yesterday, will further extend Organovo’s research capabilities. The filing read as follows:
“Organovo Holdings, Inc. (the “Company”) entered into a multi-year research collaboration agreement with Merck Sharp & Dohme Corp. (“Merck”). The Agreement will give Merck o1access to Organovo’s commercial exVive3D TM Human Liver Tissue service, and will also involve a collaboration to develop multiple custom tissue models utilizing the Company’s proprietary NovoGen Bioprinting Platform TM , for use in drug development.”
Key financial terms of the agreement have not been released. However, the market certainly liked the news yesterday as shares of Organovo closed the day up over 15%.
As the company continues to branch out, expanding their reach into multiple verticals, it will be interesting to see what ultimately comes out of these research agreements, and if perhaps a longer term acquisition plan may be in the works by either Merck or L’Oréal. After all, Murphy has been quoted as saying that he would entertain the possibility of an acquisition. Let’s hear your thoughts on this latest deal in the Merck/Organovo forum thread on 3DPB.com.
Bottom line, Vancouver is a circus run but clowns.
“All of a sudden we’re told to destroy their plants, they’ve got to buy it by mail, they have to smoke it and not eat it. So quite frankly, the federal government’s own laws, this prohibitionist approach, has created the vacuum these medical pot shops are filling.”
The government is all high out there?
Organovo Holdings (ONVO) Surges On Merck Deal
http://www.valuewalk.com/2015/04/organovo-holdings-onvo-surges-on-merck-deal/
The whole thing is laughable,.. but the funniest is one of the comments complaining that 30K is "too much". Well if this flies guess I am opening a CC in Vancouver as I say 30K is pocket change, mere peanuts for that matter in order to be able to be granted permission to open up an illegal business! This is a gift to every biker gang and criminal organization operating in Vancouver.
Q. Corruption in Vancouver?
A. Surely looks that way
Vancouver will also be issuing murder permits too, as they have decided to not take Canada's laws into account.
The whole thing is ridiculous. It appears someone in the high ranks of organized crime has a hold of a group of government officials in Vancouver. How else would one issue permits for ILLEGAL Activity? This is embarrassing for Canada.
Does anyone know who Jim Chu reports to?
It is almost like Vancouver thinks they are their own country. City council permit for 30K for an ILLEGAL business?? They are out of control.
The fellow at Cantor is probably a Short and decided to pump a $5 PT to try and put a roof on this. Surely hard for most buyers to pull a trigger on a price that is higher than the only PT out there. Cantor Pt is the hold up, wish he never pumped that low PT out.
I have a feeling we will start to see more regular news and that might be what it takes to shake the shorts and keep them from opening up more short positions to try and reverse the momentum and direction of the SP.
Without any doubt this will be surely interesting as the next few months unfold. Once the short squeeze goes into full effect, watch how she rips up as 20 million shorts chase this like fat kids on a Smartie.
Hard to say what tomorrow will entail, up or down? I say up.
Cheers,
CCD
Considering Tweed is EXACTLY 253.3 kilometers from Bob's house :),.. I would say Tweed shouldn't be cutting that much into Bob's "business". Maybe Bob should hack at Bedrocan or Supreme for a while, he might have more luck, Tweed is KING. The King will remain on the throne. Cheerio Bob.
One has to wonder, Bob/Bonno has time to make posts all day long. They surely are not investing to make a living,.. so how does Bob really make a living,.. hmmmmm. Yup, we all know. Cheerio Bob.
100 Grams a day = drug abuse, nothing more and nothing less.
The SQUEEZE should be pressing up much quicker, that Cantor $5 PT is holding the squeeze back. The fellow at Cantor is probably a Short and decided to pump a $5 PT to try and put a roof on this.
Message to the Shorts, 163 BILLION Dollar market cap companies like Merck don't sign multi-year contracts on pipe dreams. ONVO is the REAL DEAL, in time all you shorties will see.
Cheers,
CCD
Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information
http://ir.organovo.com/news/press-releases/press-releases-details/2015/Organovo-Holdings-Inc-Pre-Announces-Preliminary-Fiscal-2015-Fourth-Quarter-And-Year-End-Financial-Information/
04/21/2015
SAN DIEGO, April 21, 2015 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced preliminary financial information (unaudited) for the fourth quarter and fiscal year ended March 31, 2015.
Based on preliminary financial information for the fiscal quarter and year-ended March 31, 2015, Organovo estimates:
Total net revenues of approximately $268 thousand for the quarter, and approximately $571 thousand for the fiscal year
Total net cash utilization during fiscal 2015 fourth quarter and fiscal year ended March 31, 2015 of approximately $6.3 million and $21.1 million, respectively; and
The Company closed the year with cash and cash equivalents of approximately $50.1 million
"We are pleased to report preliminary fourth quarter and annual results which primarily reflect the initial uptake of our pre-launch product and services," said Chief Financial Officer Barry Michaels. "Fiscal 2015 was an exceptional year of accomplishment for Organovo, as we locked down our liver toxicity product and initiated commercial launch of our product and service in November. We expect to gain greater adoption from the global pharmaceutical community and look forward to partnering with them in the discovery and development of their products. Moreover, we are excited about our development progress with a kidney tissue product as well as the opportunity to expand our footprint to include applications within the cosmetics industry. We enter fiscal 2016 with confidence and momentum and look forward to continued expansion of our platform technology across multiple industries utilizing various fully cellular tissues."
We define net cash utilization as the change in the amount of cash and cash equivalents at the beginning of the reporting period as compared to the end of the reporting period, excluding financing activities ( which would include proceeds from the sale of common stock and the exercise of warrants and stock options). Net cash utilization is an operational measure that should be considered in addition to our results prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). This operational measure should not be considered as a substitute for, or superior to, GAAP results. We believe net cash utilization is a relevant and useful operational measure for the Company and our investors because it provides information regarding our cash burn rate.
Organovo will initiate quarterly earnings calls upon filing the fiscal 2015 10-K annual report with the SEC in early to mid-June, 2015. Earnings call details will be published approximately one week before the event.
About Organovo Holdings, Inc.
Organovo designs and creates functional, three-dimensional human tissues for use in medical research, cosmetic, and therapeutic applications. The Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, cosmetic, and academic partners. Organovo's 3D human tissues have the potential to accelerate the discovery process, enabling drug treatments and active agents to be developed faster and at lower cost. The company recently launched its initial product of the planned exVive3D™ portfolio offering, a 3D Human Liver Tissue for use in Toxicology and other preclinical drug testing. Additional products are in development, with anticipated release for an exVive3D™ Human Kidney Tissue in the latter half of calendar year 2016. The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications. In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous other media outlets. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.
Sign up for email updates and connect with us on Twitter (@Organovo).
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 and includes, without limitation, the preliminary financial information for the fiscal quarter and year ended March 31, 2015, the adoption rate for our liver tissue product, the development of our kidney tissue product and our opportunities in the cosmetics industry. The financial information disclosed above is preliminary and remains subject to final management review and audit by the Company's independent registered public accounting firm. As a result, the Company's actual results could differ materially and adversely from those set forth above. The Company will not update this preliminary financial information until it reports its financial results for the fiscal year ended March 31, 2015 in its annual report on Form 10-K. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the market acceptance of the Company's products; the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; and the Company discovers errors in the preliminary financial information in connection with the audit of those numbers. These and other factors are identified and described in more detail in our filings with the SEC, including our Quarterly Report on Form 10-Q filed with the SEC on February 6, 2015. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/organovo-holdings-inc-pre-announces-preliminary-fiscal-2015-fourth-quarter-and-year-end-financial-information-300069650.html
SOURCE Organovo Holdings, Inc.
Barry Michaels, Chief Financial Officer, 858-224-1000, ext. 3, IR@organovo.com, or Gerry Amato, Amato and Partners, LLC, Investor Relations, gerald@amatoandpartners.com; Media Contact, Mike Renard, EVP, Commercial Operations, 858-224-1006, mrenard@organovo.com
dont you worry boy, everything is taken care of.
Captain Delusion from the Lindsey Tin-Foil-Hat nation decided to crawl out from under that rock to once again..... blah blah blah blah
Q. Who cares what you think Bob?
A. Nobody
Austin's Bat Bridge Entertainment To Host Premiere Event For New CNN Original Series, 'High Profits,' On Sunday, April 19
http://www.prnewswire.com/news-releases/austins-bat-bridge-entertainment-to-host-premiere-event-for-new-cnn-original-series-high-profits-on-sunday-april-19-300066951.html
Weed 3: The Marijuana Revolution - Dr. Sanjay Gupta - tonite
Dr. Sanjay Gupta puts medical marijuana under the microscope again. Weed 3: The Marijuana Revolution, Sunday, at 9p ET.
http://www.cnn.com/videos/tv/2015/04/13/cnn-weed-3-4-19-2015.cnn-creative-marketing
Tweed is KING,.. will end up making the Green Giant look like Sprout.